Re-Exploring Biomarkers and Therapeutic Targets in Primary Melanoma Patients: Insights from Network-Based Analysis of Microarray Data

ABSTRACT: Objective: To identify novel biomarkers and therapeutic targets for primary melanoma using network-based microarray data analysis. Methods: Eligible microarray datasets from the Gene Expression Omnibus (GEO) database were used to identify differentially expressed genes (DEGs). The protein...

Full description

Bibliographic Details
Main Authors: Kangjie SHEN, Chuanyuan WEI, Yi XIE, Lu WANG, Shuyu WANG, Ming REN, Xinyi DENG, Daohe WANG, Zixu GAO, Zihao FENG, Jianying GU
Format: Article
Language:English
Published: KeAi Communications Co. Ltd. 2020-12-01
Series:Chinese Journal of Plastic and Reconstructive Surgery
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S209669112100042X
_version_ 1811198687197528064
author Kangjie SHEN
Chuanyuan WEI
Yi XIE
Lu WANG
Shuyu WANG
Ming REN
Xinyi DENG
Daohe WANG
Zixu GAO
Zihao FENG
Jianying GU
author_facet Kangjie SHEN
Chuanyuan WEI
Yi XIE
Lu WANG
Shuyu WANG
Ming REN
Xinyi DENG
Daohe WANG
Zixu GAO
Zihao FENG
Jianying GU
author_sort Kangjie SHEN
collection DOAJ
description ABSTRACT: Objective: To identify novel biomarkers and therapeutic targets for primary melanoma using network-based microarray data analysis. Methods: Eligible microarray datasets from the Gene Expression Omnibus (GEO) database were used to identify differentially expressed genes (DEGs). The protein-protein interaction (PPI) network, Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed to identify hub genes and pathways that might affect the survival of melanoma patients. Immunohistochemistry results obtained from the Human Protein Atlas (HPA) database confirmed the protein expression levels of hub genes. The Cancer Genome Atlas (TCGA) database was used to further verify the gene expression levels and conduct survival analysis. Results: Three microarray datasets (GSE3189, GSE15605, and GSE46517) containing 122 melanoma and 30 normal skin tissue samples were included. A total of 262 common differentially expressed genes (cDEGs) were identified based on three statistical approaches (Fisher's method, the random effects model (REM), and vote counting) with strict criteria. Of these, two upregulated genes, centromere protein F (CENPF) and pituitary tumor-transforming gene 1 (PTTG1), were selected as hub genes. HPA and TCGA database analyses confirmed that CENPF and PTTG1 were overexpressed in melanoma. Survival analysis showed that high expression levels of CENPF were significantly correlated with decreased overall survival (OS) (P=0.028). Conclusion: The expression level of CENPF was significantly upregulated in melanoma and correlated with decreased OS. Thus, CENPF may represent a novel biomarker and therapeutic target for melanoma patients.
first_indexed 2024-04-12T01:35:31Z
format Article
id doaj.art-af0cff4fda9b4f3987fc25f213ba67c1
institution Directory Open Access Journal
issn 2096-6911
language English
last_indexed 2024-04-12T01:35:31Z
publishDate 2020-12-01
publisher KeAi Communications Co. Ltd.
record_format Article
series Chinese Journal of Plastic and Reconstructive Surgery
spelling doaj.art-af0cff4fda9b4f3987fc25f213ba67c12022-12-22T03:53:20ZengKeAi Communications Co. Ltd.Chinese Journal of Plastic and Reconstructive Surgery2096-69112020-12-0124228240Re-Exploring Biomarkers and Therapeutic Targets in Primary Melanoma Patients: Insights from Network-Based Analysis of Microarray DataKangjie SHEN0Chuanyuan WEI1Yi XIE2Lu WANG3Shuyu WANG4Ming REN5Xinyi DENG6Daohe WANG7Zixu GAO8Zihao FENG9Jianying GU10Department of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, ChinaDepartment of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, ChinaDepartment of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China; The First Clinical Medical College of Nanjing Medical University, Nanjing, Jiangsu 210029, ChinaDepartment of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, ChinaDepartment of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China; The First Clinical Medical College of Nanjing Medical University, Nanjing, Jiangsu 210029, ChinaDepartment of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, ChinaDepartment of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, ChinaDepartment of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, ChinaDepartment of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, ChinaDepartment of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Department of Plastic Surgery, Xiamen Branch of Affiliated Zhongshan Hospital of Fudan University, Xiamen, Fujian 361015, China; Corresponding authors: Jianying Gu, MD, PhD & Zihao Feng, MD, Address: Department of Plastic Surgery, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Xuhui District, Shanghai 200032, China, Tel./Fax: 021-64437963Department of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Department of Plastic Surgery, Xiamen Branch of Affiliated Zhongshan Hospital of Fudan University, Xiamen, Fujian 361015, China; Corresponding authors: Jianying Gu, MD, PhD & Zihao Feng, MD, Address: Department of Plastic Surgery, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Xuhui District, Shanghai 200032, China, Tel./Fax: 021-64437963ABSTRACT: Objective: To identify novel biomarkers and therapeutic targets for primary melanoma using network-based microarray data analysis. Methods: Eligible microarray datasets from the Gene Expression Omnibus (GEO) database were used to identify differentially expressed genes (DEGs). The protein-protein interaction (PPI) network, Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed to identify hub genes and pathways that might affect the survival of melanoma patients. Immunohistochemistry results obtained from the Human Protein Atlas (HPA) database confirmed the protein expression levels of hub genes. The Cancer Genome Atlas (TCGA) database was used to further verify the gene expression levels and conduct survival analysis. Results: Three microarray datasets (GSE3189, GSE15605, and GSE46517) containing 122 melanoma and 30 normal skin tissue samples were included. A total of 262 common differentially expressed genes (cDEGs) were identified based on three statistical approaches (Fisher's method, the random effects model (REM), and vote counting) with strict criteria. Of these, two upregulated genes, centromere protein F (CENPF) and pituitary tumor-transforming gene 1 (PTTG1), were selected as hub genes. HPA and TCGA database analyses confirmed that CENPF and PTTG1 were overexpressed in melanoma. Survival analysis showed that high expression levels of CENPF were significantly correlated with decreased overall survival (OS) (P=0.028). Conclusion: The expression level of CENPF was significantly upregulated in melanoma and correlated with decreased OS. Thus, CENPF may represent a novel biomarker and therapeutic target for melanoma patients.http://www.sciencedirect.com/science/article/pii/S209669112100042XMelanomaNetwork-based analysisMicroarrayCentromere protein FBiomarkers
spellingShingle Kangjie SHEN
Chuanyuan WEI
Yi XIE
Lu WANG
Shuyu WANG
Ming REN
Xinyi DENG
Daohe WANG
Zixu GAO
Zihao FENG
Jianying GU
Re-Exploring Biomarkers and Therapeutic Targets in Primary Melanoma Patients: Insights from Network-Based Analysis of Microarray Data
Chinese Journal of Plastic and Reconstructive Surgery
Melanoma
Network-based analysis
Microarray
Centromere protein F
Biomarkers
title Re-Exploring Biomarkers and Therapeutic Targets in Primary Melanoma Patients: Insights from Network-Based Analysis of Microarray Data
title_full Re-Exploring Biomarkers and Therapeutic Targets in Primary Melanoma Patients: Insights from Network-Based Analysis of Microarray Data
title_fullStr Re-Exploring Biomarkers and Therapeutic Targets in Primary Melanoma Patients: Insights from Network-Based Analysis of Microarray Data
title_full_unstemmed Re-Exploring Biomarkers and Therapeutic Targets in Primary Melanoma Patients: Insights from Network-Based Analysis of Microarray Data
title_short Re-Exploring Biomarkers and Therapeutic Targets in Primary Melanoma Patients: Insights from Network-Based Analysis of Microarray Data
title_sort re exploring biomarkers and therapeutic targets in primary melanoma patients insights from network based analysis of microarray data
topic Melanoma
Network-based analysis
Microarray
Centromere protein F
Biomarkers
url http://www.sciencedirect.com/science/article/pii/S209669112100042X
work_keys_str_mv AT kangjieshen reexploringbiomarkersandtherapeutictargetsinprimarymelanomapatientsinsightsfromnetworkbasedanalysisofmicroarraydata
AT chuanyuanwei reexploringbiomarkersandtherapeutictargetsinprimarymelanomapatientsinsightsfromnetworkbasedanalysisofmicroarraydata
AT yixie reexploringbiomarkersandtherapeutictargetsinprimarymelanomapatientsinsightsfromnetworkbasedanalysisofmicroarraydata
AT luwang reexploringbiomarkersandtherapeutictargetsinprimarymelanomapatientsinsightsfromnetworkbasedanalysisofmicroarraydata
AT shuyuwang reexploringbiomarkersandtherapeutictargetsinprimarymelanomapatientsinsightsfromnetworkbasedanalysisofmicroarraydata
AT mingren reexploringbiomarkersandtherapeutictargetsinprimarymelanomapatientsinsightsfromnetworkbasedanalysisofmicroarraydata
AT xinyideng reexploringbiomarkersandtherapeutictargetsinprimarymelanomapatientsinsightsfromnetworkbasedanalysisofmicroarraydata
AT daohewang reexploringbiomarkersandtherapeutictargetsinprimarymelanomapatientsinsightsfromnetworkbasedanalysisofmicroarraydata
AT zixugao reexploringbiomarkersandtherapeutictargetsinprimarymelanomapatientsinsightsfromnetworkbasedanalysisofmicroarraydata
AT zihaofeng reexploringbiomarkersandtherapeutictargetsinprimarymelanomapatientsinsightsfromnetworkbasedanalysisofmicroarraydata
AT jianyinggu reexploringbiomarkersandtherapeutictargetsinprimarymelanomapatientsinsightsfromnetworkbasedanalysisofmicroarraydata